1834 Investment Advisors’s Biogen BIIB Stock Holding History

1834 Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-125	Closed	-$25K	–	223
2022 Q2	$25K	Hold	125	–	–	﹤0.01%	320
2022 Q1	$26K	Hold	125	–	–	﹤0.01%	294
2021 Q4	$30K	Hold	125	–	–	﹤0.01%	299
2021 Q3	$35K	Hold	125	–	–	﹤0.01%	291
2021 Q2	$43K	Hold	125	–	–	0.01%	281
2021 Q1	$35K	Hold	125	–	–	﹤0.01%	286
2020 Q4	$31K	Hold	125	–	–	﹤0.01%	288
2020 Q3	$35K	Hold	125	–	–	0.01%	279
2020 Q2	$33K	Hold	125	–	–	0.01%	264
2020 Q1	$40K	Sell	125 -80	-39%	-$24.3K	0.01%	263
2019 Q4	$61K	Hold	205	–	–	0.01%	262
2019 Q3	$48K	Buy	205 +80	+64%	+$18.6K	0.01%	280
2019 Q2	$29K	Hold	125	–	–	﹤0.01%	315
2019 Q1	$30K	Hold	125	–	–	﹤0.01%	310
2018 Q4	$38K	Hold	125	–	–	0.01%	283
2018 Q3	$44K	Hold	125	–	–	0.01%	283
2018 Q2	$36K	Hold	125	–	–	0.01%	297
2018 Q1	$34K	Hold	125	–	–	0.01%	303
2017 Q4	$40K	Buy	+125	New	+$40.1K	0.01%	303

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

1834 Investment Advisors's BIIB Position: Q3 2022 in Review

1834 Investment Advisors sold out of Biogen (BIIB) in Q3 2022, closing a stake of 125 shares — an estimated $25K sold.

1834 Investment Advisors first reported a position in BIIB in Q4 2017 and held it in 19 quarters. The position peaked at $61K in Q4 2019. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

1834 Investment Advisors reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
1834 Investment Advisors sold 125 Biogen shares in Q3 2022, an estimated $25K.
1834 Investment Advisors first reported a position in Biogen in Q4 2017 and held it in 19 quarters.
1834 Investment Advisors's Biogen position peaked at $61K in Q4 2019.
985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.